Healthcare providers and Labs attain real-time insights for improved patient care using SAS Viya

What is SAS Viya?

SAS Viya is a cloud-enabled, in-memory analytics engine that provides quick, accurate, and reliable analytical insights. Elastic, scalable, and fault-tolerant processing addresses the complex analytical challenges of today, while effortlessly scaling for the future.

Benefits of SAS Viya

SAS Viya helps your organization conquer all kinds of analytical challenges. You can:

• Empower your organization to rapidly collaborate on innovative analytics with a platform that accommodates a wide range of analytics skills.
• Solve analytics problems of any size or complexity, and rapidly deploy results for maximum return on investment.
• Gain efficiencies from a seamless, governed environment that accelerates the analytics life cycle from data preparation to discovery to deployment.?

This addition to the SAS Platform serves everyone in your organization ? from data scientists and business analysts to application developers and domain experts. It also provides the reliable, scalable, and secure analytics inventory management and governance necessary for agile IT. Your organization will be able to handle the always-changing and ever-growing range of analytical demands ? regardless of how many simultaneous users you have, what size your data is, or how often it’s refreshed.

Contract research organization Gunvatta uses SAS? Life Science Analytics Framework on Azure for clinical and health care data analysis and reporting

Since 2000, the US Food and Drug Administration (FDA) has approved more than 500 new medicines to prevent diseases, improve patients’ health and save lives. From drug discovery to FDA approval, developing a new medicine takes an average of 10 years and $2.6 billion.

The clinical research required to achieve FDA approval involves massive amounts of data. Difficulties in managing, sharing, and analyzing that data add time and cost, creating delays that affect patients’ well-being.

“The primary goal is to get drugs approved so that they can reach patients,” says Bhawna Goel, CEO of Gunvatta, a contract research organization (CRO) headquartered in Washington, DC. “The faster you can do that, the greater benefit for the patient and to help save lives.”

Founded in 2021, Gunvatta’s fast-growing list of current and prospective clients includes pharmaceutical companies that hire CROs to help collect, manage, analyze and visualize terabytes of data produced in clinical trials, then prepare that data for review by health authorities such as the FDA and the Pharmaceuticals and Medical Devices Agency (PMDA).

Gunvatta, which means “quality” in Hindi, also helps hospitals, medical device manufacturers, academic and research institutions, and government agencies with time-sensitive healthcare analytics solutions to support clinical and executive decision-making.